Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | Kaufen |
Orderbuch | Realtime Stuttgart | Fundamentalanalyse | Insidertrades | Fonds | Senden | |
Historisch | Realtime Push | myNews | Anleihen | im Forum |
Inhaber | in % |
---|---|
Freefloat | 95,10 |
Fidelity Management & Research Co. LLC | 14,93 |
Vanguard Group, Inc. (Subfiler) | 8,41 |
T. Rowe Price Associates, Inc. (Investment Management) | 7,68 |
Bellevue Asset Management AG | 6,24 |
BB Biotech AG | 5,87 |
Fidelity Growth Company Fund | 5,76 |
BB Biotech AG (13F) | 5,58 |
ClearBridge Investments LLC | 5,21 |
Wellington Management Co. LLP | 4,80 |
2015 | 2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 428 | 435 | 547 | 737 | 817 |
Umsatz pro Mitarbeiter in Mio. USD | 0,66 | 0,80 | 0,93 | 0,81 | 1,37 |
2015 | 2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 837 | 798 | 1.168 | 2.208 | 2.721 |
Summe Anlagevermögen | 682 | 689 | 938 | 1.695 | 2.259 |
Summe Aktiva | 956 | 912 | 1.322 | 2.668 | 3.233 |
2015 | 2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 481 | 589 | 607 | 647 | 788 |
Summe Fremdkapital | 755 | 813 | 903 | 1.481 | 1.549 |
Summe Eigenkapital | 201 | 100 | 419 | 1.187 | 1.685 |
Summe Passiva | 956 | 912 | 1.322 | 2.668 | 3.233 |
2855 Gazelle Court, 92010 Carlsbad | |
Tel: | 1.760.931.9200 |
Fax: | 1.760.918.3592 |
Internet | http://www.ionispharm.com |
B. Lynne Parshall Director |
Breaux B. Castleman Independent Outside Director |
Brett P. Monia Chief Executive Officer & Director |
Brian Lemay Vice President-Tax |
C. Frank Bennett Chief Scientific Officer |
D. Wade Walke VP-Corporate Communications & Investor Relations |
Darren Gonzales Chief Accounting Officer |
Elizabeth L. Hougen Chief Financial Officer & SVP-Finance |
Eric E. Swayze Senior Vice President-Research |
Eugene Schneider Chief Clinical Development Officer & Executive VP |
Frederick T. Muto Independent Outside Director |
Joan Elizabeth Herman Independent Director |
Joel Edwards Vice President-Corporate & Commercial Operations |
Joel Ekstorm Vice President-Information Technology |
Joseph H. Wender Independent Outside Director |
Joseph Loscalzo Independent Outside Director |
Joseph R. Klein Independent Outside Director |
Matt Buck Vice President-Regulatory Affairs |
Michael R. Hayden Independent Director |
Onaiza Cadoret-Manier Chief Corporate Development & Commercial Officer |
Patrick R. O'Neil Secretary, Chief Compliance Officer & SVP-Legal |
Peter N. Reikes Independent Director |
Richard S. Geary Chief Development Officer & Executive VP |
Sanjay Bhanot Chief Medical Officer |
Shannon Devers Vice President-Human Resources |
Spencer R. Berthelsen Independent Outside Director |
Stanley T. Crooke Executive Chairman |
Online Brokerage über finanzen.net
ETF-Sparplan